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Abstract  
We aimed to evaluate the feasibility of Cognitive Therapy (CT) as an intervention for 
internalised stigma in people with psychosis. We conducted a single-blind randomised 
controlled pilot trial comparing CT plus treatment as usual (TAU) with TAU only. 
Participants were assessed at end of treatment (4 months) and follow-up (7 months). Twenty-
nine participants with schizophrenia spectrum disorders were randomised. CT incorporated 
up to 12 sessions over 4 months (mean sessions = 9.3). Primary outcome was the Internalised 
Stigma of Mental Illness Scale – Revised (ISMI-R) total score, which provides a continuous 
measure of internalised stigma associated with mental health problems. Secondary outcomes 
included self-rated recovery, internalised shame, emotional problems, hopelessness and self-
esteem. Recruitment rates and retention for this trial were good. Changes in outcomes were 
analysed following the intention-to-treat principle, using ANCOVAs adjusted for baseline 
symptoms. There was no effect on our primary outcome, with a sizable reduction observed in 
both groups, but several secondary outcomes were significantly improved in the group 
assigned to CT, in comparison with TAU, including internalised shame, hopelessness and 
self-rated recovery. Stigma-focused CT appears feasible and acceptable in people with 
psychosis who have high levels of internalised stigma. A larger, definitive trial is required. 
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1. Introduction 
Goffman originally described stigma as ‘an attribute which is deeply discrediting’ and 
as ‘an undesired differentness’, and described internalised stigma as identification with a 
negative stereotype (Goffman 1963). Social cognitive models suggest that stigma is 
comprised of cognitive (stereotypes and prejudice), affective (prejudice) and behavioural 
(discrimination) components which drive and maintain stigma (Corrigan, Kerr et al. 2005), 
and stigma has been defined as a concept which incorporates, labelling, stereotyping, 
separation, status loss and discrimination (Link and Phelan 2001). Stigma and discrimination 
can have negative effects on mental wellbeing in many ways, and people with a psychiatric 
diagnosis are seen as dangerous, unpredictable, different, and unlikely to recover (Crisp, 
Gelder et al. 2000; Crisp, Gelder et al. 2005; Wood, Birtel et al. 2014) . The extent to which 
psychosis is stigmatised has been widely recognised and it is one of the most stigmatised 
mental health problems (Thornicroft, Brohan et al. 2009; Brohan, Elgie et al. 2010). People 
with psychosis are often stereotyped as dangerous and unpredictable and the public express 
the greatest desire for increased social distance from people with psychosis (Angermeyer and 
Matschinger 2003; Angermeyer and Matschinger 2003; Lincoln, Arens et al. 2008), and 
stigma has been described by service users as more disabling than schizophrenia itself, 
resulting in a second ‘illness’ (Finzen 1996). Service users have identified stigma, in 
particular media images, as a negative influence on suicide, and have identified stigma as a 
priority in suicide prevention (Eagles, Carson et al. 2003). Other psychological conditions 
such as depression, social anxiety and low self-esteem may occur as a direct consequence of 
stigma (Birchwood, Mason et al. 1993; Birchwood, Trower et al. 2007; Corrigan and Watson 
2007).  
It has been suggested that stigma has two major dimensions; public stigma and self-
stigma (Corrigan and Watson 2002).  Public stigma is said to incorporate three components; 
negative attitudes, beliefs/stereotypes, and discriminatory behaviour. Self-stigma or 
internalised stigma is the internalisation of these components, defined as. “the internalisation 
of shame, blame, hopelessness, guilt and fear of discrimination associated with mental 
illness”(Corrigan and Watson 2002) . A high proportion of service users with a diagnosis of 
schizophrenia report moderate to high levels of internalised stigma (Brohan, Elgie et al. 
2010). A recent systematic review found a strong negative relationship between internalised 
stigma and a range of psychosocial variables including hope, self-esteem, empowerment and 
adherence with treatment, and a strong positive relationship with psychiatric symptoms 
(Livingston and Boyd 2010). Stigma associated with psychosis can: discourage people from 
seeking help (Thornicroft 2007), which may delay treatment; lead to social isolation, which 
can exacerbate problems (Link, Struening et al. 1997; Thornicroft, Brohan et al. 2009); act as 
a mechanism of social exclusion, which hampers recovery (Link, Struening et al. 1997; Link, 
Struening et al. 2001; Ritsher and Phelan 2004); reduce employment and education 
opportunities (Link, Struening et al. 1997; Thornicroft, Brohan et al. 2009); result in poorer 
physical healthcare, suicidality, and higher mortality rates (Thornicroft, Rose et al. 2007). 
In the UK, the NICE Guidelines for Schizophrenia prioritise the reduction of stigma 
(National Institute for Health and Care Excellence 2014) and the World Health 
Organisation’s early psychosis declaration, has a primary objective to ‘Challenge 
stigmatising and discriminatory attitudes so that young people are not disadvantaged by their 
experiences’ (Bertolote and McGorry 2005). Finding ways to challenge internalised stigma 
could have important benefits for people with psychosis, but there are relatively few studies 
evaluating interventions that specifically target internalised stigma (Wiecznski 2000; Link, 
Stuening et al. 2002).  Existing research regarding the reduction of internalised stigma in 
people with serious mental health problems such as psychosis have utilised group-based 
interventions to date. These studies have shown some promise regarding the use of cognitive 
therapy (CT) and/or psychoeducational approaches to reducing internalised stigma, as well as 
improving self-esteem, recovery and empowerment (Knight, Wykes et al. 2006; MacInnes 
and Lewis 2008; Lucksted, Drapalski et al. 2011). However, most have been small-scale 
studies, with serious methodological limitations including no use of randomisation, blinding 
or independent assessment, and often lacking a control condition. Recently, there have been 
two randomised controlled trials (RCTs) of group interventions incorporating CT techniques. 
One study in Hong Kong randomised 66 people with a diagnosis of schizophrenia to a 12 
session CT-based stigma reduction programme in a group format, or a newspaper reading 
group. They found benefits in self-esteem post-treatment, but these were not maintained at 
follow-up  (Tsang 2014). An RCT in the USA compared a narrative enhancement / CT 
approach to reducing internalised stigma to treatment as usual (TAU) in 39 people with 
severe mental health problems (mostly schizophrenia spectrum disorders). They found that 
the treatment was acceptable and feasible but no differences in outcome were observed 
(Yanos, Roe et al. 2012). A recent meta-analysis of RCTs of effectiveness of programs for 
reducing the stigma associated with mental health problems in general (rather than specific to 
psychosis) found that the pooled effect size across three studies, including the 2 preceding 
trials, was not statistically significant (Griffiths, Carron-Arthur et al. 2014).  
CT for most mental health problems would hope to reduce internalised stigma as a 
result of processes such as normalisation, development of an idiosyncratic case formulation 
and the evaluation of negative beliefs about self, even if the primary outcome or treatment 
target was not self-stigma. There is some evidence for this in people with psychotic 
experiences, since a secondary analysis of the EDIE-2 trial, in which participants at high risk 
of developing psychosis (but not yet meeting criteria for a diagnosis of a psychotic disorder) 
received a CT intervention (compared to TAU), demonstrated that internalised stereotypes 
about psychotic experiences were significantly reduced in the intervention group (Morrison, 
Birchwood et al. 2013). However, no study has examined the efficacy of individual CT for 
internalised stigma in people meeting criteria for psychotic disorders, and it is possible that 
an intervention where the primary focus is the reduction of internalised stigma may be better 
suited to this purpose. Therefore, the aim of this pilot trial was to evaluate the feasibility and 
acceptability of an individualised CT intervention for internalised stigma in people with 
psychosis, and to generate data that will facilitate the calculation of power for a definitive 
trial.  Hypotheses included that CT would be acceptable and would reduce the severity of 
internalised stigma and promote recovery and self-esteem in people with psychosis, in 
comparison to TAU at both end of treatment and follow up.  This study followed guidance 
outlined by the MRC (Medical Research Council 2000) for complex interventions 
(representing a phase II/pilot study), in order to examine identification of appropriate 
outcome measures, estimates of recruitment and attrition, acceptability and feasibility of the 
intervention and a preliminary analysis of treatment effects. 
2. Methods 
2.1 Study design 
We conducted a single-blind, pilot RCT between May 2013 and September 2014 at a 
centre in the North West of England. The study protocol was approved by the National 
Research Ethics Service of the UK’s National Health Service (reference 10/H1011/61). 
2.2 Participants 
Trial entry criteria were that participants were in contact with mental health services, 
and either met ICD-10 criteria for schizophrenia, schizoaffective disorder or delusional 
disorder or met entry criteria for an Early Intervention for Psychosis service (operationally 
defined using PANSS) in order to allow for diagnostic uncertainty in early phases of 
psychosis and the fact that most early episode cases within the UK will receive their services 
from such specialist teams, consistent with NICE guidelines (2014). Participants also had to 
score >60 on the Internalised Stigma of Mental Illness Scale-Revised (ISMI-R), as indicative 
of at least moderate difficulties associated with internalised stigma; this cut-off was chosen 
on the basis of both distribution of scores from a large sample of service user participants 
(Ritsher, Otilingam et al. 2003) and face validity in terms of item response. Participants were 
identified via care coordinators and relevant mental health staff within participating mental 
health trusts. Ten participants (34%) had a diagnosis of a schizophrenia spectrum disorder, 
four (14%) had a diagnosis of bipolar disorder with psychotic features, one (3%) was 
diagnosed with schizoaffective disorder, and the remaining 14 (47%) were had experienced a 
first episode of psychosis and were receiving care from an early intervention for psychosis 
team. Eleven participants were referred from Community Mental Health Teams, 16 from 
Early Intervention Services, and one each from Assertive Outreach and Criminal Justice 
Liaison. Exclusion criteria were: moderate to severe learning disability; organic impairment; 
participants not having the capacity to consent to research participation; non-English 
speaking participants (since this would prevent the use of standardised assessment 
instruments); acute inpatient settings; primary diagnosis of a drug or alcohol dependency; and 
concurrent psychological therapy. All participants provided written informed consent.  
2.3 Randomisation and masking 
Participants were randomly assigned electronically (1:1) by an administrator using the 
computerised system Sealed Envelope (https://www.sealedenvelope.com) with permuted 
blocks of four, six and eight, to receive CT plus TAU and monitoring, or to TAU plus 
monitoring.  Email notifications of the allocation were sent to trial therapists and the trial’s 
principal investigator. The trial assessor was independent of the randomisation process and 
blind to group allocation in order to facilitate unbiased rating of a semi-structured interview 
measure of stigma (SIMS: a measure developed specifically for this study) at the baseline, 4 
and 7 month follow-ups. Several procedures were used to protect the blind: therapists had 
separate office space from the trial assessor; therapists and the trial assessor were required to 
consider diary arrangements in view of potential blind breaks; and participants were 
reminded not to talk about treatment allocation with the trial assessor. Two blind breaks 
occurred (7% of the sample), both involving participants in TAU and were reported using a 
standard form.  
2.4 Sample Size 
We chose a recruitment target of 30 in order to be able to evaluate feasibility of 
recruitment and retention and suitability of outcome measures. The proposed sample size is 
adequate to obtain reliable sample size estimates (Browne 1995),  and facilitate the main aims 
of a pilot trial, including feasibility of trial procedures and a production of a realistic power 
calculation for a future definitive study. Power calculations are not recommended for a 
feasibility trial (Lancaster, Dodd et al. 2004). 
2.5 Measures 
The primary outcome was total score on the ISMI-R which was assessed at baseline, 4 
months and 7 months, since this was also used for entry criteria. The ISMI-R is a 29-item 
questionnaire assessing internalised stigma covering four subscales: ‘alienation’; ‘stereotype 
endorsement’; ‘perceived discrimination’; and ‘social withdrawal’. Items are scored on a 4-
point Likert scale, from strongly disagree to strongly agree. Total scores were calculated by 
summing the items. This measure was revised by the research team such that the term ‘mental 
illness’ in its original form was replaced with ‘mental health problems’. This was in response 
to consultation with a service user reference group during the study design stage, who 
advised that many service users reject the idea of being ‘mentally ill’ and that such 
terminology may in-itself be stigmatising for participants. Since the wording was changed, 
the internal consistency of the revised scale was examined with our sample using the baseline 
data; it was found to have good reliability (alpha = 0.86).  
Secondary outcomes included the Semi-Structured Interview Measure of Stigma 
(SIMS), a clinician-administered, 11-item semi-structured interview based on three categories 
of stigma identified in the literature: ‘perceived stigma’; ‘experienced stigma’; and 
‘internalised stigma’.  Items are scored between 0 (not present) to 4 (severe). This interview 
schedule was developed specifically for this trial, and is currently being validated; however, 
within this sample we examined the psychometric properties and found good internal 
reliability (alpha = 0.84) and good convergent validity (the Pearson’s correlation with the 
ISMI-R was r = 0.66, p<0.001).  A shortened 16-item version of the Stigma Scale (KSS; 
(King, Dinos et al. 2007)) was used as a further measure of stigma. Items are scored on a 5-
point Likert scale, from strongly disagree to strongly agree. This shortened version included 
the subscales of ‘disclosure’ and ‘positive aspects’, but not the ‘discrimination’ subscale 
which is less likely to capture change over time. The Process of Recovery Questionnaire – 
Short form (QPR (Law, Neil et al. 2014)) was used to measure user-defined recovery. This is 
a 15-item questionnaire which was developed collaboratively with service users and which 
measures subjective recovery.  Items are scored on a 5-point Likert scale, from disagree 
strongly to agree strongly. The Beck Depression Inventory for Primary Care (BDI-7; (Winter, 
Steer et al. 1999)) was used to measure depression. It is a 7-item scale and a score of greater 
than 3 indicates a probable diagnosis of major depressive disorder. The Beck Hopelessness 
Scale (BHS; (Beck, Weissman et al. 1974)) was used to measure hopelessness. It consists of 
20 true/false items covering three factors: ‘feelings about the future’, ‘loss of motivation’; 
and ‘future expectations’. The Social Interaction Anxiety Scale (SIAS; (Mattick and Clarke 
1998)) was used to measure social anxiety. It is a 20-item questionnaire with responses 
scored on a 5-point Likert scale from ‘not at all characteristic or true of me’ to ‘extremely 
characteristic or true of me’ with scores of 36 and over indicating a probable diagnosis of 
social anxiety disorder. Self-esteem was measured using the Self-Esteem Rating Scale – 
Short form (SERS-S; (Lecomte, Corbiere et al. 2006)), a 20-item questionnaire with 
responses scored on a 7-point Likert scale from never to always with higher scores indicating 
higher self-esteem. Finally, internalised shame was measured using the Internalised Shame 
Scale (ISS; (Cook 1987)), a 30-item questionnaire with responses scored on a 5-point Likert 
scale from never to almost always. We did not include a measure of psychotic symptoms on 
the basis of feedback from our service user reference group, who felt that a focus on such 
symptoms in the assessment process but not the treatment process would be confusing for 
participants and provide an inconsistent message. 
2.6 Procedures 
All participants received their routine treatment plus monitoring, which provided 
benefits over routine care because it aimed to provide warm, empathic, and non-judgemental 
face-to-face contact, supportive listening, and signposting to appropriate local services for 
unmet needs.  Most assessments and therapy sessions took place in participants’ homes. 
2.7 Intervention 
In addition to routine treatment, participants allocated to the therapy condition 
received the individual CT intervention. This comprised a maximum of twelve hourly 
sessions over a 4 month period, and was based on a specific cognitive model of psychosis 
(Morrison 2001), with supplementary disorder specific models being used if appropriate (e.g. 
Clark and Wells model of social anxiety (Clark and Wells 1995)).  The assessment phase 
collaboratively explored the participants’ experiences of psychosis and stigma, and identified 
a stigma-related problem list and goal (this took several sessions for some participants).  The 
intervention included a number of CT techniques, but these were focused on working towards 
the stigma-related goals: guided discovery, skills development, normalising and belief change 
strategies, including behavioural experiments targeting stigma-relevant appraisals and 
evaluation of negative beliefs about self, including public stereotypes of psychosis. In 
addition, time was allocated to allow for exploration of the meaning of participants’ 
diagnoses, validation of experiences of stigma and discrimination, and consideration of pros 
and cons of different ways of responding to stigma and discrimination. Therapy was 
enhanced by the use of published normalising guided self-help manuals, which include 
chapters such as ‘Are my experiences abnormal?’, ‘What is normal?’ and ‘Feeling good 
about yourself’ (Morrison, Renton et al. 2008).  Four therapists contributed to the delivery of 
cognitive therapy. The number of participants treated by each therapist ranged from 1 to 6 
(Mean=2.8, SD=2.4). Three therapists were clinical psychologists (doctoral level) and one 
was a trainee clinical psychologist. All therapists received additional training associated with 
the trial protocol as outlined above and regular clinical supervision. Fidelity was not 
examined formally due to lack of funding; however, we would expect fidelity to be 
reasonable, since trial specific supervision of all therapists was provided by the first author. 
All participants received treatment as usual plus the three assessment sessions 
(incorporating an interview focused on experiences of stigma and discrimination from a 
research assistant), which represents an enhancement over routine care since it aimed to 
provide warm, empathic and non-judgemental face-to-face contact, supportive listening, 
signposting to appropriate local services for unmet needs and crisis management when 
required (usually by referral to a local crisis team, early intervention service or psychiatric 
liaison within emergency departments). Treatment as usual was variable, with care mostly 
being received from Community Mental Health Teams (CMHTs) or early intervention 
services (EIS). In practice, those within EIS (5 in CT, 33.3% vs 11 in TAU, 78.6%) received 
regular care-coordination and psychosocial interventions including the offer of family 
interventions and the potential to receive CT, whereas those from other community based 
services (10 in CT, 66.7% vs 3 in TAU, 21.4%) often received little other than irregular 
contact with care coordinators. 
2.8 Statistical analysis 
Analyses were undertaken in SPSS (version 20) after completion of endpoint 
assessments; primary analysis was by intention-to-treat. Changes in all outcomes were 
analysed using ANCOVA with summed scores as dependent variables and the baseline value 
of the relevant outcome measure as a covariate. We analysed end of treatment and follow-up 
separately in order to utilise all available data, on the assumption that data were Missing at 
Random (Little and Rubin 2002).  
3. Results 
INSERT FIGURE 1, CONSORT DIAGRAM 
INSERT TABLE 1, DESCRIPTIVES TABLE AT BASELINE by group 
INSERT TABLE 2: MEANS, SDs, F, p values at 4 MONTHS AND 7 MONTHS 
Figure 1 shows the trial profile. In terms of feasibility of the trial, it is clear from 
Figure 1 that recruitment was relatively successful, with a final sample that was 97% of the 
initial target.  In total, 29 individuals were randomised, with 15 allocated to CT plus 
monitoring and 14 allocated to TAU plus monitoring.  The referral to randomisation ratio was 
2:1 and no participants declined participation after having being assessed as eligible, 
suggesting good willingness to be randomised and to consider CT for internalised stigma in 
psychosis.  Baseline characteristics were similar between groups (Table 1), and a two-tailed t-
test revealed no significant difference between groups on the primary outcome measure; 
however, age and proportion within EIS appeared different (with TAU being younger and 
more likely to be recruited from EIS). Retention within the trial was good with just one 
withdrawal in the TAU group (Figure 1), and missing data rates of 10.3% at 4 months and 
6.9% at 7 months. 
Engagement with CT was reasonable. Four participants randomised to therapy did not 
attend any sessions: two reported having changed their minds post-randomisation; one was 
unwilling to travel to a service location and could not be seen at home due to risk issues; one 
participant did not receive their allocation letter and an administrative error led to this not 
being followed up. Of those participants who did attend therapy, 9 (82%) had at least 6 or 
more sessions (which is a threshold we have used in previous trials to constitute a reasonable 
‘dose’), with an average of 9.8 (SD=3.3, Range 3-13). Participants were interviewed about 
their experiences of stigma-focused CT, but the detailed results of these qualitative analyses 
are reported elsewhere (Wood, Burke et al. 2016); briefly, CT was found to be valuable by 
the majority of participants and psychoeducation, normalisation and feeling understood were 
identified as the most important elements. 
Table 2 shows the results of the primary and secondary outcomes at end of treatment 
and follow-up (means and SDs, F statistics, alpha values and effect sizes (Cohen’s d)). 
Starting with the primary outcome (ISMI-R total scores), it can be seen that there is no 
significant difference between CT and TAU at either end of treatment or follow-up; however, 
visual examination would suggest a small, non-significant benefit of CT, and the difference 
in standard deviations of the two groups is likely to cause statistical problems. Looking at the 
secondary outcomes, the estimated effects for all secondary outcomes are favouring CT, but 
not all are statistically significant. At end of treatment, we found a significant effect in favour 
of CT for internalised shame (ISS), depression (BDI-7), hopelessness (BHS) and self-rated 
recovery (QPR). However, it did not significantly improve internalised stigma (SIMS and 
KSS), social anxiety (SIAS) or self-esteem (SERS) at end of treatment, and none of the 
differences remained significant at follow-up. The majority of the observed effect sizes are in 
the moderate range (0.5-0.8).  
Three potential serious adverse events were recorded during the trial; one was in a 
participant in the CT condition (a voluntary hospital admission which happened during the 
course of therapy) and two were participants in TAU (one attempted overdose followed by a 
voluntary hospital admission and one other voluntary hospital admission). These potential 
adverse events and hospital admissions were in separate participants, and none were 
considered related to trial participation.  
4. Discussion 
To our knowledge, this is the first RCT of individual CT for people with psychosis 
who have been selected on the basis of high levels of internalised stigma. Our trial has shown 
that CT is an acceptable intervention for people with psychosis experiencing high levels of 
internalised stigma, with relatively low drop-out/withdrawal rates and the majority of those 
allocated to CT receiving at least 6 sessions. We also demonstrated that CT for this 
population does significantly reduce the severity of several relevant variables in this 
population, although there was no statistically significant difference on our primary outcome 
measure. CT significantly improved levels of internalised shame, depression, hopelessness, 
and self-rated recovery. It did not improve internalised stigma, social anxiety or self-esteem, 
although all the observed changes were in the desired direction but did not reach statistical 
significance. These results are consistent with findings from the clinical trials of group CT for 
internalised stigma to date; most trials have shown some promise, often on indirect measures 
such as self-esteem, depression and hopelessness, but have been underpowered to detect 
small to moderate effect sizes. The fact that we observed changes in internalised shame and a 
favourable trend for an interview-based measure of dimensions of internalised stigma 
suggests that individual CT may be capable of achieving more specific effects, and the 
examination of the effect sizes are also encouraging, although caution should be exercised in 
interpreting these since underpowered pilot trials are prone to findings that are not replicated 
in future definitive studies. There are a number of possible explanations for the lack of a 
between group effect on our primary outcome, other than lack of statistical power or an 
absence of an effect of treatment. It is possible that the change in wording resulting from 
service user input, in order to make the items less stigmatising, may have reduced the 
sensitivity or validity of the measure; similarly, the lack of a specified time frame in this 
measure may have been problematic. However, it is evident that there was a significant 
reduction at end of treatment in both groups (approximately 11 points in each group, on a 
measure with a standard deviation of 11 at baseline), which was sustained at follow-up. This 
suggests that both groups significantly reduced in internalised stigma over the trial; one 
possibility is that this is due to the differences in community teams that were providing 
routine care to the participants (with 78% in TAU vs 33% in CT receiving care from EIS, in 
which a core aspect of service philosophy is to reduce stigma and routine access to CT is 
more likely), while another possibility is that there are therapeutic benefits associated with 
the conversations that are facilitated by the SIMS interview that encourages discussion and 
reflection on experiences of stigma and discrimination, and the cognitive, behavioural and 
emotional dimensions of such experiences. Future trials in this area should consider 
stratification of randomisation or standardisation of entry criteria by type of community team 
or service philosophy and document TAU received for individual participants and further 
research should explore potential benefits of semi-structured interviews such as the SIMS.   
Our trial demonstrates methodological rigour in several ways, including a 
combination of self-report and interview measures, blinding of assessments, concealment of 
allocation and independent randomisation. However, there are also several methodological 
difficulties with our trial. We did not correct for multiple comparisons (for example, using 
Bonferroni’s correction); however, we only had one primary outcome, and given that this was 
a pilot study, it would seem overly conservative to apply a more stringent alpha for secondary 
outcomes. The lack of an active control group that included non-specific factors such as 
contact time, warmth and empathy, also means that we are unable to exclude the possibility 
that the observed effects were due to such non-specific factors. The trial was not registered 
with a trial registry since it was an unfunded feasibility study with no intention to produce 
definitive results. However, this is still a limitation. The lack of funding also resulted in 
stretched resources, which contributed to the failure to engage 2 participants (due to an 
administrative error and a risk/setting-related difficulty). We had several measures of 
internalised stigma, which did not demonstrate a clear consistency in terms of sensitivity to 
change. Our interview measure, which was developed due to perceived limitations in the 
existing measures (including use of some items assessing lifetime prevalence, which are very 
unlikely to change in a short-term clinical trial), appeared most sensitive to detecting a 
possible treatment effect (showing a strong trend in favour of CT). The lack of a measure of 
psychotic experiences, while based on service user input to the trial design, does mean it was 
not possible to describe our sample in these terms or to examine relationships between 
internalised stigma and such experiences. Future trials in this area should give careful 
consideration to appropriate outcome measures that are sensitive to change. The exclusion of 
people who were in inpatient settings also limits generalisability to those with acute episodes 
requiring admission to hospital, who are a population likely to be troubled by internalised 
stigma. Perhaps most importantly, our trial had very low statistical power with a small sample 
size; therefore, an adequately powered definitive randomised controlled trial is required.  
There are several clinical implications arising from this study, although they need to 
be considered very cautiously, given the limitations of an underpowered pilot study. It would 
seem that targeting internalised stigma in people with psychosis who report high levels of 
stigma is feasible and acceptable. There is some encouragement that a relatively short-term 
intervention that focuses on internalised stigma can result in changes in internalised shame, 
self-rated recovery, depression and hopelessness. It is important to assess internalised stigma 
in people with psychosis, and CT may be an appropriate approach to address this if the 
person prioritises it as problematic and an appropriate shared stigma-relevant goal can be 
established. It is also encouraging that both groups reduced in internalised stigma, and it is 
possible that other factors, such as normalising interactions with mental health professionals 
in EIS, open discussions about stigma facilitated by the SIMS and an expansion of social 
networks resulting from CT and EIS may be helpful in reducing self-stigma. However, 
further research is required. 
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TABLE 1: Baseline characteristics of the sample 
 
 Whole sample 
(N=29) 
CBT (N =15) TAU (N =14) 
Mean (SD) Mean (SD) Mean (SD) 
Age (years) 34.34 (13.26) 39.00 (13.50) 29.36 (10.02) 
Male: Female ratio 23:6 12:3 11:3 
ISMI-R 80.34 (11.06) 78.27 (9.40) 82.57 (12.57) 
SIMS 24.52 (6.64) 23.80 (7.37) 25.29 (5.93) 
KSS 41.93 (9.84) 40.07 (11.87) 43.79 (7.27) 
QPR 27.056(11.76) 27.50 (9.12) 26.31 (14.43) 
BDI-7 10.04 (5.41) 10.50 (4.16) 9.57 (6.56) 
BHS 12.97 (6.30) 13.57 (5.52) 12.37 (7.16) 
SIAS 50.22 (16.14) 48.94 (16.56) 51.50 (16.22) 
ISS 77.85 (23.27) 76.26 (24.01) 79.43 (23.30) 
SERS 65.43 (24.07) 66.43 (24.01) 64.43 (25.00) 
 
 
TABLE 2: Descriptive statistics, ANCOVA results and effect sizes (Cohen’s d) at 4 and 7 
months 
 
Variable  End of 
treatment (4 
months) 
Mean (SD) 
Follow-up 
(7 months) 
Mean (SD) 
End of treatment Follow-up 
CBT TAU CBT TAU F p d F p d 
ISMI-R* 67.29 
(10.09) 
71.20 
(16.34) 
66.62 
(9.71) 
69.26 
(18.38) 
0.052 0.822 0.09 0.046 0.832 0.09 
SIMS 17.45 
(7.47) 
22.81 
(7.96) 
15.35 
(7.98) 
19.01 
(7.77) 
2.97 0.099 0.65 1.50 0.236 0.41 
KSS 34.75 
(8.82) 
40.32 
(6.57) 
32.76 
(9.73) 
38.69 
(7.33) 
2.27 0.146 0.49 1.98 0.173 0.50 
QPR 38.71 
(7.55) 
25.75 
(14.59) 
39.17 
(11.22) 
31.58 
(14.41) 
12.84 0.002 1.10 3.34 0.082 0.67 
BDI-7 6.33 
(4.21) 
9.15 
(5.21) 
6.83 
(4.57) 
6.92 
(5.24) 
4.39 0.048 0.59 .376 0.546 0.16 
BHS 7.12 
(5.23) 
10.77 
(6.31) 
9.42 
(6.57) 
10.25 
(7.31) 
7.73 0.011 0.72 1.81 0.191 0.38 
SIAS 39.58 
(19.32) 
48.77 
(17.82) 
37.00 
(19.26) 
46.91 
(17.83 
1.95 0.177 0.51 3.19 0.088 0.68 
ISS 61.18 
(18.36) 
74.00 
(22.51) 
60.00 
(29.13) 
67.31 
(24.53) 
4.84 0.039 0.56 .796 0.382 0.34 
SERS 79.00 70.62 83.58 73.15 1.70 0.206 0.34 2.87 0.104 0.55 
(23.03) (25.06) (29.84) (24.96) 
NB * ISMI-R was the primary outcome 
 
 
 
 
 
 
 
Figure 1: Participant flow 
 
Highlights  
 Stigma-focused CT is feasible and acceptable in people experiencing psychosis who 
have internalised stigma 
 CT showed promise for reducing internalised shame and hopelessness and improving 
self-rated recovery  
 A definitive, appropriately powered trial is required and appears both feasible and 
deliverable 
